ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,444Medicare Part D Prescriptions Filled, Including Refills

Rank: 42 out of 2456

$863K Total Retail Price of All Prescriptions

Rank: 65 out of 2456

360 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 360 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 360 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 14,909 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
WARFARIN SODIUM 969 951 1 9
LISINOPRIL 560 485 2 1
OMEPRAZOLE 536 501 3 3
AMLODIPINE BESYLATE 527 522 4 5
FUROSEMIDE 394 385 5 8
METOPROLOL TARTRATE 371 324 6 10
ZOLPIDEM TARTRATE 351 310 7 28
SIMVASTATIN 345 306 8 2
TRAZODONE HCL 307 295 9 17
METFORMIN HCL 291 282 10 11
NAMENDA 283 283 11 42
GLYBURIDE 274 245 R 12 40
ATORVASTATIN CALCIUM 267 260 13 12
GABAPENTIN 262 201 14 16
PRAVASTATIN SODIUM 260 222 15 15
METOPROLOL SUCCINATE 240 218 16 13
HYDROCHLOROTHIAZIDE 233 216 17 7
LEVOTHYROXINE SODIUM 232 205 18 4
CITALOPRAM HBR 230 229 19 14
DONEPEZIL HCL 224 220 20 23
MIRTAZAPINE 219 218 21 29
ATENOLOL 217 202 22 6
DIOVAN 204 200 23 26
POLYETHYLENE GLYCOL 3350 179 179 24 64
FLUTICASONE PROPIONATE 163 137 25 30
QUETIAPINE FUMARATE 158 144 26 47
POTASSIUM CHLORIDE 155 148 27 33
LIDODERM 154 152 28 58
OLANZAPINE 151 151 29 57
TAMSULOSIN HCL 133 116 30 32
SERTRALINE HCL 125 124 31 21
GLIPIZIDE 120 119 32 46
ENALAPRIL MALEATE 116 115 33 70
RANITIDINE HCL 102 97 34 31
CRESTOR 101 89 35 25
ALENDRONATE SODIUM 100 96 36 19
NEXIUM 99 94 37 80
CLOPIDOGREL 99 74 37 55
PANTOPRAZOLE SODIUM 98 94 39 37
HYDROCODONE-ACETAMINOPHEN 96 56 S3 40 20
IBUPROFEN 94 71 41 52
OXYCODONE HCL 92 37 S2 42 38
ENOXAPARIN SODIUM 89 43 43 186
DIGOXIN 89 84 43 49
SUCRALFATE 88 76 45 201
LOSARTAN POTASSIUM 85 84 46 18
CYCLOBENZAPRINE HCL 81 43 R 47 77
MECLIZINE HCL 80 78 48 107
FLUOXETINE HCL 78 78 49 45
NAPROXEN 77 72 50 109
OXYCODONE-ACETAMINOPHEN 76 43 S2 51 35
PLAVIX 72 55 52 79
LIPITOR 71 71 53 63
PROAIR HFA 70 41 54 22
SPIRONOLACTONE 70 55 54 73
FINASTERIDE 67 67 56 66
ACETAMINOPHEN-CODEINE 67 53 S3 56 106
RAMIPRIL 67 55 56 158
CYMBALTA 66 47 59 65
LABETALOL HCL 65 65 60 128
NITROSTAT 63 59 61 169
PAROXETINE HCL 63 51 61 56
VERAPAMIL ER 62 50 63 91
ADVAIR DISKUS 62 57 63 36
ABILIFY 62 59 63 95
COLCRYS 61 51 66 171
NIFEDIPINE ER 61 61 66 61
RISPERIDONE 60 48 68 50
LEVOFLOXACIN 60 54 68 103
THEOPHYLLINE ANHYDROUS 59 53 70 257
VESICARE 59 59 70 205
ESCITALOPRAM OXALATE 59 59 70 116
GEMFIBROZIL 57 45 73 93
LACTULOSE 56 55 74 88
ISOSORBIDE MONONITRATE ER 53 53 75 48
TOPIRAMATE 52 39 76 162
FENTANYL 52 50 S2 76 115
CLOBETASOL PROPIONATE 51 43 78 208
LANTUS 50 42 79 44
AZITHROMYCIN 50 37 79 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.